Listed

Aura Biosciences, Inc.

AURANasdaqCIK 1501796HealthcareFiscal year ends Dec 31

Reports and events: 89 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Aura Biosciences, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0616:01 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-271351
2023-10-0216:11 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-249055
2023-08-0907:10 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-040138
2023-08-0907:05 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-040136
2023-06-0716:52 ET8-K5.07 Shareholder vote results0001193125-23-162617
2023-05-1116:27 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021302
2023-05-1116:20 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-021284
2023-04-2516:05 ETDEF 14AProxy statementPeriod 2023-06-070001193125-23-115288
2023-04-0407:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-090316
2023-03-1516:27 ET10-KAnnual reportPeriod 2022-12-310000950170-23-008166
2023-03-1516:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-008163
2023-02-1608:13 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-040742
2023-01-0617:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-003670
2022-12-0716:30 ETSC 13D/AOwnership report, active investor, amended0000902664-22-005060
2022-12-0517:12 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-22-298535
2022-11-3016:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-295368
2022-11-1007:11 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-024150
2022-11-1007:05 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-024145
2022-10-0307:05 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-256110
2022-09-2808:43 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-252714
2022-08-1116:29 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016911
2022-08-1116:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-016905
2022-06-3007:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-185580
2022-06-2217:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-178857
2022-06-1517:02 ET8-K5.07 Shareholder vote results0001193125-22-174863
2022-05-2718:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-161235
2022-05-1816:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-22-154031
2022-05-1216:33 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-009719
2022-05-1216:29 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-009706
2022-04-2816:17 ETDEF 14AProxy statementPeriod 2022-06-150001193125-22-127614
2022-03-2316:26 ET10-KAnnual reportPeriod 2021-12-310000950170-22-004425
2022-03-2316:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-004419
2021-11-2416:21 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-004908
2021-11-2416:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-004906
2021-11-1015:21 ETSC 13DOwnership report, active investor0001193125-21-325850
2021-11-0416:58 ETSC 13DOwnership report, active investor0000902664-21-004741
2021-11-0216:06 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-21-316929
2021-10-2506:06 ETS-1/ARegistration statement, amended0001193125-21-305934
2021-10-0816:38 ETS-1Registration statement0001193125-21-295543

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 18:49 ET. Listed shows no prices and gives no investment advice.